UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis

Wu, W; Zhou, G; Han, H; Huang, X; Jiang, H; Mukai, S; Kazlauskas, A; ... Lei, H; + view all (2020) PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis. Diabetes , 69 (4) pp. 739-748. 10.2337/db19-0713. Green open access

[thumbnail of Vanhaesebroeck_PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis_AAM.pdf]
Preview
Text
Vanhaesebroeck_PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis_AAM.pdf - Accepted Version

Download (4MB) | Preview

Abstract

Diabetic retinopathy is the most common microvascular complication of diabetes, characterized by the formation of fibrovascular membranes that consist of a variety of cells including vascular endothelial cells (ECs). New therapeutic approaches for this diabetic complication are urgently needed. Here, we report that in cultured human retinal microvascular (HRECs) high glucose induced expression of p110, which was also expressed in ECs of fibrovascular membranes from diabetic patients. This catalytic subunit of a receptor regulated PI3K isoform  is known to be highly-enriched in leukocytes. Using genetic and pharmacological approaches, we show that p110 activity in cultured ECs controls Akt activation, cell proliferation, migration, and tube formation induced by vascular endothelial growth factor, basic fibroblast growth factor, and epidermal growth factor. Using a mouse model of oxygen-induced retinopathy, p110 inactivation was found to attenuate pathological retinal angiogenesis. p110 inhibitors have been approved for use in human B-cell malignancies. Our data suggest that antagonizing p110 constitutes a previously-unappreciated therapeutic opportunity for diabetic retinopathy.

Type: Article
Title: PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.2337/db19-0713
Publisher version: https://doi.org/10.2337/db19-0713
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: https://discovery.ucl.ac.uk/id/eprint/10089518
Downloads since deposit
64Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item